Please login to the form below
Fovea
This page shows the latest Fovea news and features for those working in and with pharma, biotech and healthcare.
Germany's IQWiG delivers bad news for Bayer’s Eylea
The G-BA had earlier decided that Eylea would be compared to Lucentis in cases of DMO, which affected the fovea centralis - a pit in the back of the eye that ... The data showed no relevant differences between the treatment groups for patients in whom
Latest news
-
NICE gives final backing to drugs from Bayer, GSK and Otsuka
and for whom there is no permanent damage to the part of the eye called the fovea.
-
Eylea set to challenge Lucentis in UK after NICE recommendation
who show signs the condition has been getting worse and for whom there is no permanent damage to the part of the eye called the fovea.
-
S-A signs ophthalmology deal
The ophthalmology division of sanofi-aventis (S-A), Fovea Pharmaceuticals, has signed a co-operation agreement with the Institut de la Vision (page is in French), one of the main eye
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
Kala Pharma appoints Fovea founder Bernard Gilly to board
Dr Gilly, along with Professor Jose Sahel and Pierre Belichard, set up Fovea in 2005. ... Prior to his involvement with Fovea, Dr Gilly was a venture partner with Sofinnova Partners from 2000 to 2005.
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
-
Account Manager
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Publications Director
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Associate Account Director
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
-
Medical Editor
-
Competitive Salary
-
Senior Medical Writer
-
Competitive Salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- Merck & Co reveals plans for women’s health spinoff Organon
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- bluebird bio aiming to separate business units by year-end
- AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
- Sharing patient stories for World Pulmonary Hypertension Day
- AZ, Daiichi Sankyo reveal new TNBC data for next-gen antibody drug conjugate
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine
- Pfizer, BioNTech file for full US approval of COVID-19 vaccine
- The impact of cancer on mental health during COVID-19
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
- The new reality of building a corporate brand in pharma
- FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- Sharing patient stories for World Pulmonary Hypertension Day
- For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
- How nature can help you manage the pressures of agency life
- Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
